Intradermal immunotherapy with low-dose house dust mite allergens in patients with allergic rhinitis: A proof-of-concept study. Rev Alerg Mex [Internet]. 2018 Apr. 10 [cited 2026 Sep. 24];65(1):41-5. Available from: https://www.revistaalergia.mx/ojs/index.php/ram/article/view/322